• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

犬组织细胞肉瘤中TP53基因双碱基插入突变的临床意义

Clinical significance of the two-base insertion mutation in the TP53 gene in canine histiocytic sarcoma.

作者信息

Asada Hajime, Tomiyasu Hirotaka, Okada Kazuki, Chambers James K, Goto-Koshino Yuko, Uchida Kazuyuki, Kagawa Yumiko, Ohno Koichi, Tsujimoto Hajime

机构信息

Department of Veterinary Internal Medicine, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Bunkyo-ku, Tokyo 113-8657, Japan.

Department of Veterinary Internal Medicine, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Bunkyo-ku, Tokyo 113-8657, Japan.

出版信息

Res Vet Sci. 2019 Jun;124:57-60. doi: 10.1016/j.rvsc.2019.03.003. Epub 2019 Mar 5.

DOI:10.1016/j.rvsc.2019.03.003
PMID:30852355
Abstract

Canine histiocytic sarcoma (HS) is an aggressive tumor type originating from dendritic cells or macrophages. We previously reported high incidence of the two-base (AT) insertion mutation (insAT) in the tumor protein p53 (TP53) gene in dogs with HS, and the aim of this study was to investigate the clinical significance of insAT in canine HS. The present study established a sensitive digital PCR-based assay for detecting insAT and examined its associations with clinical variables and survival time. The mutation was detected in 26 of 64 dogs (41%), and the mean mutant allele frequency was 1.9% (range, 0.014-35%), indicating that not all tumor cells harbor insAT. The incidence of insAT was significantly higher in dogs with metastatic lesions than in those without metastatic lesions. However, the existence of insAT was not associated with survival time or response to chemotherapy with lomustine or nimustine. This study suggested that HS cells might acquire insAT in the TP53 gene during development of metastasis, but insAT was not a prognostic factor in canine HS. Further studies are needed to investigate the contribution of insAT to the development of metastatic lesions of canine HS.

摘要

犬组织细胞肉瘤(HS)是一种起源于树突状细胞或巨噬细胞的侵袭性肿瘤类型。我们之前报道过患有HS的犬肿瘤蛋白p53(TP53)基因中两碱基(AT)插入突变(insAT)的高发生率,本研究的目的是调查insAT在犬HS中的临床意义。本研究建立了一种基于数字PCR的灵敏检测方法来检测insAT,并研究其与临床变量和生存时间的关联。在64只犬中的26只(41%)检测到该突变,平均突变等位基因频率为1.9%(范围为0.014 - 35%),这表明并非所有肿瘤细胞都携带insAT。有转移病灶的犬中insAT的发生率显著高于无转移病灶的犬。然而,insAT的存在与生存时间或对洛莫司汀或尼莫司汀化疗的反应无关。本研究表明,HS细胞可能在转移发生过程中获得TP53基因中的insAT,但insAT不是犬HS的预后因素。需要进一步研究来调查insAT对犬HS转移病灶发展的作用。

相似文献

1
Clinical significance of the two-base insertion mutation in the TP53 gene in canine histiocytic sarcoma.犬组织细胞肉瘤中TP53基因双碱基插入突变的临床意义
Res Vet Sci. 2019 Jun;124:57-60. doi: 10.1016/j.rvsc.2019.03.003. Epub 2019 Mar 5.
2
A 2-base insertion in exon 5 is a common mutation of the TP53 gene in dogs with histiocytic sarcoma.外显子5中的2碱基插入是组织细胞肉瘤犬中TP53基因的常见突变。
J Vet Med Sci. 2017 Oct 20;79(10):1721-1726. doi: 10.1292/jvms.17-0197. Epub 2017 Sep 1.
3
Effect of a two-base insertion mutation of the gene on expression of p53 protein in canine histiocytic sarcoma cells.基因的双碱基插入突变对犬组织细胞肉瘤细胞中p53蛋白表达的影响。
Am J Vet Res. 2019 Jul;80(7):680-688. doi: 10.2460/ajvr.80.7.680.
4
The intratumor heterogeneity of TP53 gene mutations in canine histiocytic sarcoma.犬组织细胞肉瘤中TP53基因突变的肿瘤内异质性
J Vet Med Sci. 2019 Mar 14;81(3):353-356. doi: 10.1292/jvms.18-0419. Epub 2019 Jan 18.
5
Evaluation of the drug sensitivity and expression of 16 drug resistance-related genes in canine histiocytic sarcoma cell lines.犬组织细胞肉瘤细胞系中16种耐药相关基因的药敏性及表达评估
J Vet Med Sci. 2015 Jun;77(6):677-84. doi: 10.1292/jvms.14-0415. Epub 2015 Feb 21.
6
PTPN11 mutations in canine and human disseminated histiocytic sarcoma.犬和人弥散性组织细胞肉瘤中的 PTPN11 突变。
Int J Cancer. 2020 Sep 15;147(6):1657-1665. doi: 10.1002/ijc.32991. Epub 2020 Apr 8.
7
Survivin suppressor (YM155) enhances chemotherapeutic efficacy against canine histiocytic sarcoma in murine transplantation models.生存素抑制剂(YM155)在小鼠移植模型中增强了对犬组织细胞肉瘤的化疗疗效。
Res Vet Sci. 2015 Apr;99:137-44. doi: 10.1016/j.rvsc.2015.02.003. Epub 2015 Feb 11.
8
Canine Histiocytic and Hemophagocytic Histiocytic Sarcomas Display and Extensive /SHP2 Mutations and Respond In Vitro to MEK Inhibition by Cobimetinib.犬组织细胞和噬血细胞组织细胞肉瘤表现出 和广泛的 SHP2 突变,并在体外对考比替尼的 MEK 抑制有反应。
Genes (Basel). 2024 Aug 9;15(8):1050. doi: 10.3390/genes15081050.
9
Epirubicin in the treatment of canine histiocytic sarcoma: sequential, alternating and rescue chemotherapy.表阿霉素治疗犬组织细胞肉瘤:序贯、交替和挽救化疗。
Vet Comp Oncol. 2018 Mar;16(1):E30-E37. doi: 10.1111/vco.12329. Epub 2017 Jun 15.
10
Gain-of-function mutation in PTPN11 in histiocytic sarcomas of Bernese Mountain Dogs.伯恩山犬组织细胞肉瘤中PTPN11的功能获得性突变。
Vet Comp Oncol. 2018 Jun;16(2):220-228. doi: 10.1111/vco.12357. Epub 2017 Sep 20.

引用本文的文献

1
Therapeutic effect of nimustine in a dog with intracranial histiocytic sarcoma.尼莫司汀治疗颅内组织细胞肉瘤犬的疗效。
Open Vet J. 2024 Oct;14(10):2700-2706. doi: 10.5455/OVJ.2024.v14.i10.20. Epub 2024 Oct 31.
2
Review of Molecular Technologies for Investigating Canine Cancer.用于研究犬类癌症的分子技术综述
Animals (Basel). 2024 Feb 29;14(5):769. doi: 10.3390/ani14050769.
3
Intratumoral heterogeneity of c-KIT mutations in a feline splenic mast cell tumor and their functional effects on cell proliferation.猫脾脏肥大细胞瘤中 c-KIT 基因突变的瘤内异质性及其对细胞增殖的功能影响。
Sci Rep. 2022 Sep 22;12(1):15791. doi: 10.1038/s41598-022-19089-5.